January 27, 2017
Beximco 16% sales rise drives profit up for the half year
Beximco Pharmaceuticals has posted earnings of $1,113,722, for the second half of 2016, compared to $944,662 to the same period last year.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 27, 2017
Stallergenes reports positive results for a p3 clinical study of allergic rhinitis in children
Stallergenes Greer, a biopharmaceutical company specializing in treatments for respiratory allergies, has reported positive topline results for a phase 3 clinical…
January 26, 2017
Novartis’s eye health division launches IOL
Alcon and a division of Novartis have launched AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery.
January 26, 2017
Advanced Oncotherapy welcomes Professor Steve Myers and Hans von Celsing as Non-Executive Directors
Advanced Oncotherapy has appointed Professor Steve Myers OBE and Hans von Celsing as Non-Executive Directors. Hans von Celsing will become Senior…
January 26, 2017
UPDATE: Johnson & Johnson buys Actelion for $30 billion
Johnson & Johnson said on Wednesday it will buy a Switzerland-based pharmaceutical company Actelion for $30 billion.
January 26, 2017
Ablynx, Merck KGaA report encouraging results from psoriasis treatment study
Ablynx and Merck KGaA (Germany) have reported encouraging results from a study in psoriasis patients with the bi-specific Nanobody anti-IL-17A/F (M1095), via a clinical trials website (https://clinicaltrials.gov/NCT02156466).
January 26, 2017
Sensorion receives €950,000 from Bpifrance and the Occitania Region
Bpifrance and the Occitania region of Southern France have selected to support Sensorion, a biotechnology company specializing in the treatment…
January 25, 2017
Onxeo completes enrollment in ReLive trial for hepatocellular carcinoma drug
Onxeo S.A., a biopharmaceutical company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular…
January 25, 2017
NeuroVive redirects its research resources and activities back home
NeuroVive Pharmaceutical will redirect its Taiwan-based subsidiary’s research resources and activities to the parent company NeuroVive Pharmaceutical.
January 25, 2017
ImmuPharma recruits patients for Lupus drug testing
ImmuPharma has provided details of patient recruitment into its pivotal 52-week Phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough compound for Lupus.